Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sarah L. Demmon"'
Autor:
Michael Dougan, Masoud Azizad, Peter Chen, Barry Feldman, Matthew Frieman, Awawu Igbinadolor, Princy Kumar, Jason Morris, Jeffrey Potts, Lauren Baracco, Lisa Macpherson, Nicole L. Kallewaard, Dipak R. Patel, Matthew M. Hufford, Linda Wietecha, Emmanuel Chigutsa, Sarah L. Demmon, Bryan E. Jones, Ajay Nirula, Daniel M. Skovronsky, Mark Williams, Robert L. Gottlieb
BACKGROUNDBebtelovimab is a potent, fully human IgG1 monoclonal antibody (mAb) targeting the S-protein of SARS-CoV-2, with broad neutralizing activity to all currently known SARS-CoV-2 variants of concern, including omicron variant lineages. Speciali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a89960690dccd85b26106e30598d68e
https://doi.org/10.1101/2022.03.10.22272100
https://doi.org/10.1101/2022.03.10.22272100
Autor:
Edward Koepf, Sarah L Demmon, Marisa K. Joubert, Swapnil Bhargava, Phillip Smith, Philip Tsai, Nomalie Jaya, Doreen Ciolek, Melody Trexler-Schmidt, Jennifer Halley
Publikováno v:
Biologicals. 67:9-20
Identification of Critical Quality Attributes (CQAs) and subsequent characterization in process development studies are the key elements of quality by design (QbD) for biopharmaceutical products. Since the inception of ICH Q8R2, several articles have
Autor:
Cynthia A Payne, Mark B. Effron, Ganapathy Gopalrathnam, Sarah L Demmon, Debra A Boelk, Mark D Williams, Henry J. Mann, Natarajan Rajagopalan, Gregory M Beck
Publikováno v:
ResearcherID
PURPOSE: The physical and chemical compatibility of drotrecogin alfa (activated) (recombinant human activated protein C) during simulated Y-site administration with drugs commonly used to treat patients with severe sepsis was determined. METHODS: Thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::551bbb8a8077fbd03144d2a364934cbe
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000225924500009&KeyUID=WOS:000225924500009
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000225924500009&KeyUID=WOS:000225924500009